Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 19/20 | 0.49 |
| ▸ | PARP2 | Q9UGN5 | 6/20 | 0.48 |
| ▸ | PARP3 | Q9Y6F1 | 5/20 | 0.48 |
| ▸ | PARP6 | Q2NL67 | 4/20 | 0.48 |
| ▸ | TIPARP | Q7Z3E1 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25693065 | 0.86 | HDAC3 (0.57) | PARP1PARP2PARP3PARP6TIPARP | |
| SCHEMBL18135103 | 0.85 | NPC1 (0.56) | PARP1PARP2PARP3PARP6TIPARP | |
| SCHEMBL30230133 | 0.84 | AKR1C3 (0.46) | HDAC3HDAC2 | |
| SCHEMBL25246829 | 0.83 | HRH3 (0.57) | HDAC3HDAC2 | |
| SCHEMBL30064367 | 0.83 | SCD (0.54) | PARP1HDAC3HDAC2 | |
| SCHEMBL22912831 | 0.82 | SMN1; SMN2 (0.65) | — | |
| SCHEMBL29396475 | 0.82 | SMN1; SMN2 (0.65) | — | |
| SCHEMBL30065247 | 0.82 | SCD (0.49) | PARP1PARP2PARP3PARP6KCNH2 | |
| SCHEMBL27397948 | 0.82 | PARP1 (0.58) | PARP1PARP2PARP3PARP6TIPARP | |
| SCHEMBL22912811 | 0.82 | HDAC2 (0.55) | PARP1PARP2PARP3PARP6TIPARP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4355749-A1 | TRICYCLIC PARP1 INHIBITORS AND USES THEREOF | Xinthera, Inc. (US) | 2024-04-24 | — | — | EP | disclosed |
| WO-2023212219-A1 | TRICYCLIC PARP1 INHIBITORS AND USES THEREOF | XINTHERA, INC. (US) | 2023-11-02 | — | — | WO | disclosed |